306 related articles for article (PubMed ID: 16868548)
1. Targeting of somatic hypermutation.
Odegard VH; Schatz DG
Nat Rev Immunol; 2006 Aug; 6(8):573-83. PubMed ID: 16868548
[TBL] [Abstract][Full Text] [Related]
2. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
[TBL] [Abstract][Full Text] [Related]
3. Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines.
Rückerl F; Busse B; Bachl J
Mol Immunol; 2006 Apr; 43(10):1645-52. PubMed ID: 16310251
[TBL] [Abstract][Full Text] [Related]
4. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas.
Martin A; Bardwell PD; Woo CJ; Fan M; Shulman MJ; Scharff MD
Nature; 2002 Feb; 415(6873):802-6. PubMed ID: 11823785
[TBL] [Abstract][Full Text] [Related]
5. Role of AID in tumorigenesis.
Okazaki IM; Kotani A; Honjo T
Adv Immunol; 2007; 94():245-73. PubMed ID: 17560277
[TBL] [Abstract][Full Text] [Related]
6. A/T-targeted somatic hypermutation: critique of the mainstream model.
Franklin A; Blanden RV
Trends Biochem Sci; 2006 May; 31(5):252-8. PubMed ID: 16616496
[TBL] [Abstract][Full Text] [Related]
7. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
Komori A; Xu Z; Wu X; Zan H; Casali P
Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
[TBL] [Abstract][Full Text] [Related]
8. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
Yang SY; Fugmann SD; Schatz DG
J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
[TBL] [Abstract][Full Text] [Related]
9. AID mutates a non-immunoglobulin transgene independent of chromosomal position.
Parsa JY; Basit W; Wang CL; Gommerman JL; Carlyle JR; Martin A
Mol Immunol; 2007 Jan; 44(4):567-75. PubMed ID: 16542725
[TBL] [Abstract][Full Text] [Related]
10. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
[TBL] [Abstract][Full Text] [Related]
11. Activation-induced deaminase: light and dark sides.
de Yébenes VG; Ramiro AR
Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038
[TBL] [Abstract][Full Text] [Related]
12. Reflections on the state of play in somatic hypermutation.
Steele EJ
Mol Immunol; 2008 May; 45(10):2723-6. PubMed ID: 18359085
[TBL] [Abstract][Full Text] [Related]
13. Topologically Associated Domains Delineate Susceptibility to Somatic Hypermutation.
Senigl F; Maman Y; Dinesh RK; Alinikula J; Seth RB; Pecnova L; Omer AD; Rao SSP; Weisz D; Buerstedde JM; Aiden EL; Casellas R; Hejnar J; Schatz DG
Cell Rep; 2019 Dec; 29(12):3902-3915.e8. PubMed ID: 31851922
[TBL] [Abstract][Full Text] [Related]
14. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
[TBL] [Abstract][Full Text] [Related]
15. Strand-biased spreading of mutations during somatic hypermutation.
Unniraman S; Schatz DG
Science; 2007 Aug; 317(5842):1227-30. PubMed ID: 17761884
[TBL] [Abstract][Full Text] [Related]
16. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
[TBL] [Abstract][Full Text] [Related]
17. Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations.
Epeldegui M; Hung YP; McQuay A; Ambinder RF; Martínez-Maza O
Mol Immunol; 2007 Feb; 44(5):934-42. PubMed ID: 16730063
[TBL] [Abstract][Full Text] [Related]
18. AID and Igh switch region-Myc chromosomal translocations.
Unniraman S; Schatz DG
DNA Repair (Amst); 2006 Sep; 5(9-10):1259-64. PubMed ID: 16784901
[TBL] [Abstract][Full Text] [Related]
19. Two levels of protection for the B cell genome during somatic hypermutation.
Liu M; Duke JL; Richter DJ; Vinuesa CG; Goodnow CC; Kleinstein SH; Schatz DG
Nature; 2008 Feb; 451(7180):841-5. PubMed ID: 18273020
[TBL] [Abstract][Full Text] [Related]
20. Identification of core DNA elements that target somatic hypermutation.
Kohler KM; McDonald JJ; Duke JL; Arakawa H; Tan S; Kleinstein SH; Buerstedde JM; Schatz DG
J Immunol; 2012 Dec; 189(11):5314-26. PubMed ID: 23087403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]